Related Experiment Video
Updated: Aug 5, 2026

12:08
Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
Published on: May 17, 2019
The Pentose Phosphate Pathway in Immunotherapy
Rachel D Loo1, John Blazeck1,2,3,4,5
1School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta GA, USA.
Journal of Leukocyte Biology
|August 3, 2026
Summary
The pentose phosphate pathway (PPP) is crucial for T cell function in cancer immunotherapy. Understanding its role in T cell metabolism can improve cancer treatments.
Area of Science:
- Immunology
- Cellular Metabolism
- Cancer Research
Background:
- Cellular metabolism significantly impacts cancer and T cell survival, particularly in adoptive cell immunotherapy.
- T cells utilize glycolysis for proliferation and effector functions, but the pentose phosphate pathway's (PPP) role is less understood.
- The PPP generates antioxidants and biosynthetic precursors, influencing cellular redox balance and biosynthesis.
Purpose of the Study:
- To review the pentose phosphate pathway's role in regulating T cell activation, redox balance, and antitumor function.
- To explore the PPP's differential effects on CD8+ and CD4+ T cell differentiation and antitumor responses.
- To discuss metabolic regulators of PPP enzymes and potential immunotherapy strategies.
Main Methods:
- Literature review of existing research on T cell metabolism and the pentose phosphate pathway.
- Analysis of the PPP's function in T cell activation, exhaustion, and differentiation.
- Synthesis of information on metabolic regulators and their impact on PPP enzyme expression.
Main Results:
- The PPP acts as a time-dependent regulator of T cell activation and redox balance.
- The PPP is associated with enhanced functional capacity in exhausted T cells.
- The PPP plays distinct roles in CD8+ and CD4+ T cell differentiation, influencing antitumor immunity.
- A link exists between the glycogen-PPP axis and CD8+ memory T cells.
Conclusions:
- The pentose phosphate pathway is a key regulator of T cell metabolism with significant implications for antitumor immunity.
- Targeting the PPP offers potential therapeutic strategies for enhancing adoptive cell immunotherapy.
- Further research into PPP regulation and its interplay with other metabolic pathways is warranted for optimizing cancer treatments.
Related Concept Videos
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
